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1. Summary 
In the present study we evaluated the effect of sex 
hormone on the generation of murine cytotoxic T
cell responses. We show that the in vitro CTL re- 
sponse was strongly inhibited by progesterone but 
not by El, E2 or testosterone. Our experiments at- 
tempting to understand the mechanism of the hor- 
mone action on CTL development have revealed that 
the ability of the cells to generate helper signals was 
not affected. This was demonstrated by the fact that 
neither'IL-2 production nor IL-2 receptor expression 
was altered by the hormone. Rather, it appears that 
the capacity of the cells to respond to the signals and 
to become cytotoxic was modified. Furthermore, we 
show that the hormone mediated an inhibition of 
CTL development in thymocyte cultures externally 
supplemented with all the required helper factors. 
These results trongly suggest that progesterone has 
a direct effect on the differentiation f cytotoxic ef- 
fector cells. 
2. Introduction 
In spite of the considerable data accumulating in 
the literature regarding the role played by the gona- 
dal steroid hormones in regulating immune 
responses [1-3], controversy till exists as to the im- 
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mune functions affected and the specificity of the 
regulatory hormones. Furthermore, very little is 
known, as yet, about he mechanism ofaction of the 
hormones on immune reactivities. 
Analysis of the effect of gonadal steroid hor- 
mones on the different lymphoid cell populations 
and on the functions of the immune system in the 
mouse as well as in the human have revealed a variety 
of effects that are often contradictory. In the mouse, 
a direct inhibitory activity of 17B-estradiol (E2) on 
natural killer (NK) cells was observed [4, 5]. Fur- 
thermore, O'Hearn [6] reported that E2 and 
progesterone, in concentrations that block DNA 
synthesis and CTL development, bring about a 
decreased generation ofsuppressor ceils. In vivo ad- 
ministration of E 2 and testosterone causes deple- 
tion of Lyt2 + cells in the thymus whereas only E2 
affects the periphery in a similar manner [7]. Ac- 
cording to this report, E2 mediates reduction i  IL-2 
production/cell and in suppression activity of 
splenocytes. These results are in disagreement with 
those reported by Weinstein et al. [8] showing a su- 
perior MLR and antigen presenting ability by female 
splenocytes and lymph node cells over those of 
males. This inferior capacity of male lymphocytes 
could be reversed by castration of the mice and the 
superiority of the female cell by administration f 
testosterone. 
In the human the picture is even more complex. 
An E2-induced enhanced B cell maturation via inhi- 
bition of suppressor T cells was reported by Paavo- 
nen [91, whereas aprogesterone-induced increase in 
the generation of con A-induced suppressor cells 
was shown by Holdstock [10]. 
The confusion expressed in the literature regard- 
ing the sex hormone ffect on the immune system 
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may be due to the fact that a wide range of hormone 
concentrations have been tested in different im- 
munological systems, each of which is mediated by 
different signals [1]. As to T cell activation, most of 
the studies analysed the effect of the hormones on 
proliferation, i.e., thymidine incorporation [1], 
which is the end result of the activation process, and 
not on each one of the activation steps separately. In
the present study we investigated the effect of/3- 
estradiol, progesterone, strone and testosterone on 
each one of the major steps of T cell activation and 
differentiation pathway. We put special emphasis on 
distinguishing between the hormone effect on the 
capacity of T cells to provide helper signals for their 
activation by producing helper factors, and between 
their ability to respond to these signals by generating 
receptors and by differentiating into cytotoxic T 
cells. 
3. Materials and Methods 
3.1. Mice 
Mice were bred in the animal facility of the Ger- 
man Cancer Research Center and used at 4 -  9 weeks 
of age. 
3.2. Culture medium 
The culture medium used was RPMI-1640 (Gibco; 
powdered medium) with L-glutamine (2×10 -3 M) 
and supplemented with 10% heat-inactivated fetal 
calf serum (FCS), Hepes (0.02 M), 2- 
mercaptoethanol (4×10-5M),  and gentamicin 
(50/zg/ml). 
3.3. Hormones 
Solutions (10 -3 M) of the following hormones 
were prepared in ethanol: /3-estradiol, estrone, 
testosterone, progesterone (all from Sigma). Further 
dilutions were prepared in culture medium. 
3.4. Lymphokine preparations 
Con A- (concanavalin-A; Pharmacia, Uppsala, 
Sweden) induced supernatants were prepared by 
conventional methods. Single cell suspensions from 
mouse spleens were adjusted to 107 cells/ml in cul- 
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ture medium and incubated for 24 h with con A 
5/xg/ml at 37°C in a humidified 5°70 CO 2 at- 
mosphere. All preparations were stored at 4 °C. 
3.5. Preparation of IL-2 
Partially purified IL-2 was prepared as described 
in detail elsewhere [11]. Briefly, EL-4 thymoma cells 
were activated with phorbol myristate acetate 
(PMA). IL-2 from the cell-free supernatant was fur- 
ther purified by ammonium sulfate precipitation 
and consecutive chromatography on phenyl- 
Sepharose (Pharmacia) and Sephadex G-100. 
3.6. Assay for IL-2 activity 
IL-2 in supernatants was measured by the ability 
to support growth of the IL-2-dependent cell line W- 
2 [11]. Wo2 cell proliferation was assessed following 
20 h of incubation using a 4-h [3H]thymidine pulse 
(1 #Ci of [methyl-3H]thymidine, [3H]TdR; specific 
activity 50 Ci/mmol; Amersham International Ltd., 
Amersham). 
3.7. T cell cytotoxicity assays 
Splenic or thymic responder cells at indicated 
numbers were co-cultured in a final volume of 5 ml 
or 0.16 ml medium with or without IL-2 and/or lym- 
phokine preparations, with X-irradiated (1500 rad) 
allogeneic or glutaraldehyde-fixed, TNP-haptenated 
syngeneic spleen cells as stimulators. Cytotoxic ac- 
tivity was measured on day 5 in a 4-h 5~Cr-release 
assay using 5 ×103 of either unmodified or TNP- 
modified tumor target cells: L929 mouse fibrosarco- 
ma or P815 mouse mastocytoma. The data are 
presented as specific 5~Cr release calculated as 
follows: 
(experimental release - spontaneous release) 
× 100 
(total release - spontaneous release) 
Every effector to target cell ratio was tested in tripli- 
cate. The standard error of the mean was always less 
than 2.5%. 
3.8. Proliferation assays 
Spleen cells (3 x 105) were cultured with 3 × 105 X- 
irradiated (1500 rad) allogeneic spleen cells as stimu- 
lators or with con A (4/zg/ml) in 0.2-ml cultures for 
48 h. [3H]TdR uptake was measured following a 16- 
h pulse. The results are expressed as the mean cpm 
___ SD of triplicate cultures. 
3.9. IL-2 receptor determination 
Monoclonal antibodies (AMT 13) from a rat 
hybridoma cell line directed against a murine IL-2 
receptor were a kind gift from T. Diamantstein [12]. 
Glutaraldehyde-fixed sheep erythrocytes (5x106) 
were added to the triplicate cultures of 4x105 
thymocytes and the cells were kept on ice for 30 min 
with or without 100/~1 culture supernatant contain- 
ing AMT 13 antibodies. After another incubation 
for 60 min on ice with 125I-labeled F(ab') 2 frag- 
ments of a sheep anti-rat IgG (100 #1 of a 1:10 diluted 
stock with specific activity of 12/~Ci//zg, Amers- 
ham), the ceils were washed, specific binding was 
determined and expressed as the mean cpm + SD 
of triplicate cultures. 
4. Results 
The effect of sex hormones on allogeneic stimula- 
tion of murine spleen ceils was investigated. Cocul- 
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Fig. 1. The effect of steroid hormones on CTL development in 
allogeneic spleen cell cultures. Spleen cells (2x107) of female 
BALB/c mice were cultured with X-irradiated spleen cells 
(5 x 106) from female C3H mice in 5 ml medium without or with 
10 -6 M of the indicated hormone. Following 5 days in culture, 
cells were admixed with 51Cr-labeled L929 tumor cells (5 x 103) in 
triplicate for a 4-h 51Cr release assay. 
X-irradiated splenic stimulator cells from female 
C3H mice for 5 days resulted in a cytolytic T cell re- 
sponse against L929 target cells. The presence of 
progesterone (1.25/~M) strongly inhibited the gener- 
ation of cytotoxic activity, estradiol and estrone x- 
hibited a lesser effect and testosterone was almost in- 
effective (Fig. 1). Similar results were obtained in 
C3H anti-BALB/c cultures (data not shown). 
The possibility that the reduced response seen in 
the progesterone and estradiol containing cultures 
was due to cytolysis of the effector cells by the hor- 
mones was ruled out. No decrease, but rather a slight 
increase, in the viability of cells stimulated in the 
presence of hormones, as compared to those stimu- 
lated with con A alone, was observed (Table 1). 
The lower cytotoxicity observed could be the result 
of intervention by the hormone in different stages of 
T cell activation. (a) The production of helper fac- 
tors such as IL-2. (b) The generation of receptors to 
IL-2. (c) The development of suppressor cells rather 
than cytotoxic ells. 
In order to understand the mechanism(s) respon- 
sible for the altered T cell response described above, 
we present here a study in which we investigate the 
effect of the hormones on each of the above steps: 
IL-2 production did not seem to be affected by the 
hormones. This was tested on splenocytes stimulated 
with con A and on EL4 cells stimulated with phor- 
bol myristate acetate (PMA). Hormone concentra- 
tion ranged from 10 ttM to 1/~M (data not shown). 
TABLE 1 
The effect of hormones on the viability of allogeneically stimulat- 
ed splenocytes. 
Hormone concentration Cell number 07o Recovery 
in cultures (#M) x 10 -6 
None 8.4 100 
Progesterone 2.5 8.0 95 
1.25 12.0 142 
Estradiol 2.5 8.4 100 
1.25 10.0 119 
Estrone 2.5 10.0 119 
1.25 8.4 100 
Testosterone 2.5 8.4 100 
1.25 7.6 90 
Spleen cells (2 x 107) of female BALB/c mice were cultured with 
5 x 106 irradiated spleen cells from female C3H mice in a 5-ml 
volume. Five days later the ceils were washed and viability was 
determined by trypan blue dye exclusion. 
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TABLE 2 
Effect of steroid hormones on the induction of IL-2 receptor ex- 
pression on thymocytes. 
Hormone added a AMT 13 binding b
(cpm × 10- 3) 
None 73.1 _+ 8.5 
Progesterone 84.9 _+ 12.3 
Estradiol 82.6_+ 2.8 
Estrone 70.4 _+ 10.2 
Testosterone 76.3 _+ 4 
Fresh thymocytes 6.9_+ 1.4 
a Cultures of 5 × 106 thymocytes from female C3H mice were 
supplemented with 300/zl con A-lymphokine and con A 
(5 ~tg/ml) and 1.25 t~M of the indicated hormone in a total vol- 
ume of 1 ml. b Specific binding of the anti-IL-2 receptor anti- 
bodies (AMT 13) was determined on 4 x 105 cells/sample after 
72 h. 
The level of IL-2 receptor expression, as well, was 
not affected by progesterone and estradiol (Table 2). 
To determine this, thymocytes were stimulated for 
72 h with supernatants of splenocytes stimulated 
with con A in conjunction with con A. We have used 
this system since thymocytes cannot produce IL-2 
but can generate receptors to the factor when exter- 
nal help is provided. 
In order to distinguish between the effect of the 
hormones on the generation of helper signals and 
TABLE 3 
Effect of steroid hormones on CTL development in allogeneic 
thymocyte microcultures. 
Hormone concentration % Specific lysis 
in cultures a (/~M) BALB/c anti-C3Hb 
None 53.6_+ 10.3 
Progesterone 2.5 23.6-+ 7.1 
1.25 32.9-+ 5.9 
Estradiol 2.5 42.1 -+ 6.1 
1.25 50.6-+ 5.9 
Estrone 2.5 48.1 _+ 10.6 
1.25 47.9_+ 1.4 
Testosterone 2.5 51.8_+ 7.1 
1.25 41.4_+ 7.8 
a Thymocytes (105) of female BALB/c mice were cultured with 
3× 103 X-irradiated spleen cells from female C3H mice in 
0.16 ml volume. All cultures contained partially purified IL-2 
(40 U/ml).  b After 5 days of culture, 5 x 103 labeled L929 tumor 
cells were added for 4-h 51Cr-release assay. 
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TABLE 4 
Effect of steroid hormones on CTL development in syngeneic 
thymocyte microcultures. 
Hormone concentration % Specific lysis 
in cultures a 0zM) BALB/c anti TNP C3Hb 
None 27.1 _+ 4.8 
Progesterone 2.5 6.0 +_ 0.8 
1.25 16.6+4.6 
Estradiol 2.5 17.7 _+ 2.5 
1.25 26.7 + 6.0 
Estrone 2.5 17.4 _+ 3.3 
1.25 25.0 _+ 4.9 
Testosterone 2.5 21.2 + 4.2 
1.25 30.2_+4.5 
a Thymocytes (105) of female BALB/c mice were cultured with 
3 x 105 TNP-modifled glutaraldehyde-flxed spleen cells from 
male C3H mice in 0.16 ml volume. All cultures contained 60 #1 
of supernatant of con A-stimulated splenocytes and partially pu- 
rified IL-2 (40 U/ml).  b After 5 days of culture, 5 × 103 labeled 
TNP-modified L929 cells were added for 4-h 51Cr-release assay. 
between their effect on the ability of the cells to re- 
spond to these signals we have tested the effect of the 
different hormones on the generation of allogeneic 
thymic responders. Such cultures are dependent 
upon exogenous IL-2 in order to generate CTL. 
Thus, T cell malfunction, if detected, could be solely 
related to the T cell effector arm. Indeed, the de- 
velopment of BALB/c anti-C3H (Table 3) as well as 
the C3H anti-BALB/c (data not shown) thymocyte 
response in the presence of excess amount of IL-2 
was clearly inhibited by progesterone. In this ex- 
perimental system the stimulator cells underwent X- 
irradiation (1500 rad) thus maintaining their capaci- 
ty to provide helper factors, other than IL-2, that are 
needed for the development of alloresponse. When 
using metabolically inactive stimulator cells these 
helper factors have to be added into the thymocyte 
cultures in order to get alloresponse [11]. But also in 
such lymphokine-driven thymocyte cultures, the 
generation of syngeneic CTL responses was effec- 
tively inhibited by progesterone (Table 4). Our 
results strongly suggest hat the hormone does not 
affect he production of helper signals but probably 
alters the ability of the cells to respond to these 
signals. 
To address this question we have assessed the ca- 
pacity of splenocytes toproliferate in response to al- 
logeneic or mitogenic stimuli. As seen in Tables 5 
TABLE 5 






cpm x 10- 3b 
2.5 1.25 0.6 
None 13.1 _+ 1.9 
Progesterone 4.2+_0.7 4.4+0.8 6.2-+ 1.1 
Estradiol 9.2+_ 1.2 15.6+0.7 13.6-+0.8 
Estrone 8.6+_0.9 8.5-+0.7 13.3_+0.9 
Testosterone 10.5 +_ 2.2 13.3 _+ 0.2 14.1 +_ 1.6 
a Spleen cells (3 x 105) of female BALB/c mice were cultured 
with 3 x 105 X-irradiated (1500 rad) C3H splenocytes for 48 h. 
b [3H]Thymidine incorporation was assessed following a 16-h 
pulse and is expressed as cpm of triplicate cultures. 
and 6, a concentration f as low as 0.5/~M progester- 
one strongly inhibited the proliferative capacity of 
BALB/c cells stimulated either with C3H spleen cells 
or with con A. The C3H splenocyte activation either 
by con A or by lymphokine containing superna- 
tants, as well as the DBA anti-C3H stimulation were 
similarly inhibited by progesterone (data not 
shown). No effect was detected by estradiol, estrone, 
or testosterone. These results indeed indicate that he 
hormone interferes with the generation of effector 
cells by a mechanism not yet understood. 
5. Discussion 
The data presented in this article demonstrate a 
strong inhibitory effect of progesterone, but not of 
El, E2 or testosterone, onthe generation of murine 
CTL responses. These results are consistent with 
those reported by others (for review, see ref. 1) show- 
ing a marked progesterone-mediated inhibition of 
proliferation, of rat as well as of human lympho- 
cytes, following mixed lymphocyte r action or mito- 
genic stimulation. In addition, graft rejection ex- 
periments in mice and rats have shown that the 
hormone can reduce the in vivo inflammatory 
processes. 
The concentration f the hormone used in our ex- 
periments was around 10 -6  M which is very similar 
to those present in the circulation during pregnancy 
[13-15]. Since elevated levels of circulating hor- 
mone are present during pregnancy in many animal 
models as well as in humans [1, 13-15], it is suggest- 
ed that progesterone produced by the placenta 
and/or ovaries during pregnancy may inhibit T 
lymphocyte-mediated r sponses involved in tissue 
rejection. In our study in the human, using peripher- 
al blood mononuclear cells from post-menopausal 
women [16], we could not show any effect of 
progesterone on all the immunological functions 
tested. If the hormone-mediated modulation of the 
immune response indeed plays a role in pregnancy, 
it is possible that in the post-menopausal age the 
lymphocytes lose their sensitivity to the hormones. 
Our experiments attempting to understand the 
mechanism of the hormone action on CTL develop- 
ment have revealed that the ability of the cells to 
generate helper signals was not affected. This was 
demonstrated bythe fact that neither IL-2 produc- 
tion nor IL-2 receptor expression was altered by the 
hormone. Rather, it appears that the capacity of the 
TABLE 6 
Effect of steroid hormones on the proliferation of con A-stimulated splenocytes. 
Hormone cpm × 10- 3b 
concentrations 
in culture a 2.5 1.25 0.6 
(/~M) 





143.4+ 11.9 128.1 +20.7 128.1 ___ 19.3 
210.3 + 15.1 232.3 + 10.1 207.7 + 11.7 
213.2+ 5.4 219.4+ 10.4 212.3+ 18.7 
176.0+ 9.4 182.6_+26.7 209.0_+ 9.0 
a Splenocytes (3 x 10 s) of female BALB/c mice were cultured with 4 #g/ml con A for 48 h. b [3H]Thymidine incorporation was assessed 
following a 16-h pulse and is expressed as cpm of triplicate cultures. 
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cells to respond to the signals and to become cytotox- 
ic was modif ied.  Furthermore,  the data demonstrat-  
ing an inhibit ion o f  CTL  development in thymocyte 
cultures upplemented with all the required [11] help- 
er factors (Table 4), emphasize the direct effect of  
progesterone on the dif ferentiat ion of  cytotoxic ef- 
fector cells. 
Several investigators suggest hat progesterone af- 
fects the immune response by modulat ing the gener- 
at ion and/or  the activity of  suppressor cells. Indeed, 
signif icant increase in suppressor cell activity was 
observed in a mitogen- induced suppressor T cell sys- 
tem in the human [10]. On the other hand, a direct 
inhibit ion of  suppressor cell function by progester- 
one was also reported [6]. The discrepancy between 
the two observations can be due to differences be- 
tween the experimental  systems used. However, in 
our system, it does not seem plausible that suppres- 
sor cells can play a major  role in our 5-day thymocyte 
cultures, even though this possibi l i ty has not been ex- 
per imental ly excluded. 
E 2 was found to be almost ineffective in our sys- 
tem in spite of  the relatively high concentrat ions 
used. The direct in vitro effect of  E 2 on blastogene- 
sis is rather controversial. Many investigators (for 
review, see ref. 1) including ourselves, in our study in 
the human [16], conf i rm the result presented in this 
study. However, it seems that in those cases where an 
effect could be shown it was due to the high concen- 
trat ions used [1]. 
It should be noted that there are convincing data 
as to the effect of  E 2 on other immunologica l  func- 
tions, namely, on pokeweed mitogen- induced human 
B cell d i f ferent iat ion [9, 17], on ant ibody format ion 
[18], on autoant ibody  product ion by CD5 + B cells 
[3, 19], etc. The hormone mechanism of  act ion is not 
yet understood. 
As ment ioned above, progesterone did not seem 
to modulate  IL-2 receptor expression (Table 2), how- 
ever, we cannot rule out the possibi l i ty that the hor- 
mone alters the receptor or affects differential ly the 
low aff inity receptors [20]. 
Even though the molecular  mechanisms of  the 
progesterone- induced inhibit ion of  prol i feration of  
T cells and of  CTL development have not been com- 
pletely elucidated, the observations of  this report 
support  he potential  importance of  progesterone as
an immunomodulator .  
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